Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411 (Q30434934)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411 |
scientific article |
Statements
1 reference
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411 (English)
1 reference
Christopher H Crane
1 reference
Kathryn Winter
1 reference
William F Regine
1 reference
Howard Safran
1 reference
Tyvin A Rich
1 reference
Walter Curran
1 reference
Robert A Wolff
1 reference
Christopher G Willett
1 reference
1 reference
Identifiers
1 reference